Strategic pillars
TRADITION OF INNOVATION
Bioglan AB development vectors are based on four strategic pillars, which should ensure the growth and profitability of the company in the long term and create value for all its stakeholders:
R&D
Development of:
New indications and/or dosage forms of known active principles
Generics with special focus on beta lactam and freeze dried injectable antibiotics
Topical dermatological products
OTCs
Identification of collaborative projects with start-ups and biotech research centers
Own brands
Strengthening of own brands oriented to the pharmaceutical and hospital channel.
Search for strategic opportunities to acquire international brands.
Internationalization
Agreements with licensees in the nordic markets where the company has no direct presence, for the marketing of in-house-developed prescription medicines, OTCs, medical devices, cosmetics and food supplements.
Specialized production services
Specialized manufacture for third parties, with outstanding approach in penicillanic antibiotics in all dosage forms, cephalosporanic antibiotics in vials, topical dermatologicals, and especially, freeze dried vials including biotech.